The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership

Comazzi, S.; Marconato, Laura; Argyle, David; Aresu, Luca; Stirn, Martina; Grant, Iain; Guscetti, Franco; Hendrickx, Tom; Ibisch, Catherine; Lawrence, Jessica; Polton, Gerry; Teske, Erik

doi:10.1111/vco.12128

Cited by 9 publications

(7 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The European Canine Lymphoma Network (ECLN) is a network created in 2009 with the aim of establishing cooperation among different institutions working on canine lymphoma across the fields of diagnosis and therapy . The definition of common guidelines and approaches is one of the main goals of ECLN.…”

Section: Methodsmentioning

confidence: 99%

Conformity and controversies in the diagnosis, staging and follow‐up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature

Marconato

Polton

Sabattini

et al. 2016

Vet Comparative Oncology

Self Cite

View full text Add to dashboard Cite

Diagnostic methods used in the initial and post-treatment evaluation of canine lymphoma are heterogeneous and can vary within countries and institutions. Accurate reporting of clinical stage and response assessment is crucial in determining the treatment efficacy and predicting prognosis. This study comprises a systematic review of all available canine multicentric lymphoma studies published over 15 years. Data concerning diagnosis, clinical stage evaluation and response assessment procedures were extracted and compared. Sixty-three studies met the eligibility criteria. Fifty-five (87.3%) studies were non-randomized prospective or retrospective studies. The survey results also expose variations in diagnostic criteria and treatment response assessment in canine multicentric lymphoma. Variations in staging procedures performed and recorded led to an unquantifiable heterogeneity among patients in and between studies, making it difficult to compare treatment efficacies. Awareness of this inconsistency of procedure and reporting may help in the design of future clinical trials.

show abstract

Section: Methodsmentioning

confidence: 99%

Conformity and controversies in the diagnosis, staging and follow‐up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature

Marconato

Polton

Sabattini

et al. 2016

Vet Comparative Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

“…The European Canine Lymphoma Network (ECLN) is a network that was created in 2009 with the aim of establishing cooperation among different institutions working on canine lymphoma diagnosis and therapy (11). The definition of consensus guidelines and approaches is one of the main goals of ECLN and a specific panel on FC has been formed gathering 16 participants selected on demonstrated expertise in veterinary FC.…”

Section: Methodsmentioning

confidence: 99%

European canine lymphoma network consensus recommendations for reporting flow cytometry in canine hematopoietic neoplasms

Comazzi

Avery

Garden

et al. 2016

Cytometry Part B Clinical

Self Cite

View full text Add to dashboard Cite

Background Flow cytometry (FC) is assuming increasing importance in diagnosis in veterinary oncology. The European Canine Lymphoma Network (ECLN) is an international cooperation of different institutions working on canine lymphoma diagnosis and therapy. The ECLN panel of experts on FC has defined the issue of reporting FC on canine lymphoma and leukemia as their first hot topic, since a standardized report that includes all the important information is still lacking in veterinary medicine. Methods The flow cytometry panel of the ECLN started a consensus initiative using the Delphi approach. Clinicians were considered the main target of FC reports. A panel of experts in FC was interrogated about the important information needed from a report. Results Using the feedback from clinicians and subsequent discussion, a list of information to be included in the report was made, with four different levels of recommendation. The final report should include both a quantitative part and a qualitative or descriptive part with interpretation of the salient results. Other items discussed included the necessity of reporting data regarding the quality of samples, use of absolute numbers of positive cells, cutoff values, the intensity of fluorescence, and possible aberrant patterns of antigen expression useful from a clinical point of view. Conclusion The consensus initiative is a first step toward standardization of diagnostic approach to canine hematopoietic neoplasms among different institutions and countries. This harmonization will improve communication and patient care and also facilitate the multicenter studies necessary to further our knowledge of canine hematopoietic neoplasms. © 2016 International Clinical Cytometry Society

show abstract

“…As can be appreciated, the diagnostic and therapeutic approach to canine lymphoma is currently poorly standardised, with large variations between institutions. In 2015, a European Canine Lymphoma Network was established as an initiative to generate consensus guidelines for diagnosis and therapy in canine lymphoma (Comazzi et al 2015). Further collaborative work is still required to standardise the clinical approach to canine lymphoma and thus guide and inform clinical research and decision making in this area for the future.…”

Section: Canine Lymphomamentioning

confidence: 99%

Significant advances in veterinary oncology – 60 years on

Dobson

2019

J of Small Animal Practice

View full text Add to dashboard Cite

The first edition of the Journal of Small Animal Practice published in February 1960, contained a paper entitled “Recent Treatments of Malignant Neoplasia” by Dr Larry Owen. Now we have reached the 60th anniversary of JSAP, that article provides a baseline from which to review subsequent advances in veterinary oncology, which now includes worldwide networks that have resulted in veterinary oncology becoming the multidisciplinary speciality that it is today. There certainly have been many advances in understanding of the pathology and epidemiology of animal cancers and in methods of diagnosis and treatment. However, the subject has become so large and diverse that not all aspects can be covered in detail here. It should also be acknowledged that there are still many gaps in knowledge in this field and that, because of a lack of randomised clinical trials, the evidence base for what is often regarded as “standard of care” is weak.

show abstract

The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership

Cited by 9 publications

References 7 publications

Conformity and controversies in the diagnosis, staging and follow‐up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature

Conformity and controversies in the diagnosis, staging and follow‐up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature

European canine lymphoma network consensus recommendations for reporting flow cytometry in canine hematopoietic neoplasms

Significant advances in veterinary oncology – 60 years on

Contact Info

Product

Resources

About